Brainsway (BWAY) Net Margin (2018 - 2026)
Brainsway (BWAY) posted quarterly Net Margin of 14.74% for Q1 2026, up 515.0% year-on-year from 2.4% in Q1 2025, and down 35.5% on a QoQ basis from 22.86% in Q4 2025.
Brainsway (BWAY) Net Margin (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Net Margin for 9 consecutive years, with 14.74% the latest figure, recorded in Q1 2026.
- Quarterly Net Margin rose 515.0% year-over-year to 14.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.38% (up 737.0% YoY) and the FY2025 annual result came in at 14.5%, up 738.0% from the prior year.
- Net Margin eased to 14.74% in Q1 2026 per BWAY's latest filing, from 22.86% in the prior quarter.
- Over the last five years, Net Margin for BWAY reached as high as 22.86% in Q4 2025 and fell as low as 97.5% in Q3 2022.
- A 5-year average of 10.27% and a median of 1.41% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin tumbled 7512 bps — and 2023, when it jumped 9473 bps.
- Year by year, Net Margin stood at 64.1% in 2022, then soared by 102 bps to 1.41% in 2023, then surged by 864 bps to 13.56% in 2024, then jumped by 69 bps to 22.86% in 2025, then slumped by 36 bps to 14.74% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 14.74%, 22.86%, and 11.59% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 14.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.74% |
| Dec 31, 2025 | 22.86% |
| Sep 30, 2025 | 11.59% |
| Jun 30, 2025 | 16.05% |
| Mar 31, 2025 | 9.60% |
| Dec 31, 2024 | 13.56% |
| Sep 30, 2024 | 6.30% |
| Jun 30, 2024 | 6.00% |
| Mar 31, 2024 | 1.22% |
| Dec 31, 2023 | 1.41% |
| Sep 30, 2023 | -2.77% |
| Jun 30, 2023 | -21.24% |
| Mar 31, 2023 | -36.69% |
| Dec 31, 2022 | -64.10% |
| Sep 30, 2022 | -97.50% |
| Jun 30, 2022 | -30.60% |
| Mar 31, 2022 | -25.01% |
| Dec 31, 2021 | -15.90% |
| Sep 30, 2021 | -22.38% |
| Jun 30, 2021 | -27.67% |